DK1032414T3 - Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet - Google Patents

Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet

Info

Publication number
DK1032414T3
DK1032414T3 DK98913813T DK98913813T DK1032414T3 DK 1032414 T3 DK1032414 T3 DK 1032414T3 DK 98913813 T DK98913813 T DK 98913813T DK 98913813 T DK98913813 T DK 98913813T DK 1032414 T3 DK1032414 T3 DK 1032414T3
Authority
DK
Denmark
Prior art keywords
diuretic
treatment
combination
converting enzyme
enzyme inhibitor
Prior art date
Application number
DK98913813T
Other languages
English (en)
Inventor
David Guez
Pierre Schiavi
Bernard Levy
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1032414T3 publication Critical patent/DK1032414T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98913813T 1997-11-19 1998-03-03 Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet DK1032414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714485A FR2771010B1 (fr) 1997-11-19 1997-11-19 Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
PCT/FR1998/000411 WO1999025374A1 (fr) 1997-11-19 1998-03-03 Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires

Publications (1)

Publication Number Publication Date
DK1032414T3 true DK1032414T3 (da) 2003-09-01

Family

ID=9513523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98913813T DK1032414T3 (da) 1997-11-19 1998-03-03 Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet

Country Status (21)

Country Link
US (1) US6653336B1 (da)
EP (1) EP1032414B1 (da)
JP (1) JP2001523646A (da)
CN (1) CN1227029C (da)
AT (1) ATE239500T1 (da)
AU (1) AU740748B2 (da)
BR (1) BR9814885A (da)
CA (1) CA2310136C (da)
DE (1) DE69814444T2 (da)
DK (1) DK1032414T3 (da)
EA (1) EA002968B1 (da)
ES (1) ES2198708T3 (da)
FR (1) FR2771010B1 (da)
HK (1) HK1033096A1 (da)
HU (1) HU226022B1 (da)
NO (1) NO20002479D0 (da)
NZ (1) NZ504220A (da)
PL (1) PL340561A1 (da)
PT (1) PT1032414E (da)
WO (1) WO1999025374A1 (da)
ZA (1) ZA986673B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
BRPI0209720A2 (pt) * 2001-05-31 2017-06-13 Microdose Tech Inc dosagem e embalagem de medicação com liberação controlada
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril
CA2537180A1 (en) * 2003-08-29 2005-03-10 Cotherix, Inc. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
CN1292747C (zh) * 2003-09-16 2007-01-03 广东省心血管病研究所 一种用于治疗高血压的复方制剂
EA011712B1 (ru) * 2004-03-29 2009-04-28 Ле Лаборатуар Сервье Способ производства твёрдой фармацевтической композиции
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
WO2008068577A2 (en) * 2006-12-01 2008-06-12 Glenmark Pharmaceuticals Limited Pharmaceutical compositions
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CA2850520C (en) * 2011-09-29 2021-08-31 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
CA2215234C (en) * 1995-03-16 2001-12-11 Pfizer Inc. Composition containing amlodipine, or its salt and an ace inhibitor

Also Published As

Publication number Publication date
US6653336B1 (en) 2003-11-25
CN1227029C (zh) 2005-11-16
EA002968B1 (ru) 2002-12-26
WO1999025374A1 (fr) 1999-05-27
FR2771010A1 (fr) 1999-05-21
EP1032414A1 (fr) 2000-09-06
EA200000536A1 (ru) 2000-10-30
FR2771010B1 (fr) 2003-08-15
PT1032414E (pt) 2003-08-29
CA2310136A1 (fr) 1999-05-27
AU740748B2 (en) 2001-11-15
DE69814444D1 (de) 2003-06-12
PL340561A1 (en) 2001-02-12
HK1033096A1 (en) 2001-08-17
ZA986673B (en) 1999-02-04
HUP0004544A3 (en) 2001-07-30
EP1032414B1 (fr) 2003-05-07
JP2001523646A (ja) 2001-11-27
NO20002479L (no) 2000-05-12
CA2310136C (fr) 2004-04-20
AU6837798A (en) 1999-06-07
NZ504220A (en) 2003-05-30
ATE239500T1 (de) 2003-05-15
CN1279615A (zh) 2001-01-10
DE69814444T2 (de) 2004-03-18
HUP0004544A2 (hu) 2001-06-28
BR9814885A (pt) 2000-10-03
HU226022B1 (en) 2008-03-28
ES2198708T3 (es) 2004-02-01
NO20002479D0 (no) 2000-05-12

Similar Documents

Publication Publication Date Title
DK1032414T3 (da) Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
EA200000768A1 (ru) ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
TR200103216T2 (tr) Pirimidinon bileşimleri
DK0833839T3 (da) Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme
BR9908280A (pt) Inibidores de enzimas de fosfolipase
ID23877A (id) Senyawa-senyawa dan metode-metode untuk penghambatan ekspresi vcam-1
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
ATE225772T1 (de) Thrombin-inhibitoren
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
EA199900837A1 (ru) Способ применения ингибиторов циклооксигеназы-2 для предупреждения сердечно-сосудистых расстройств
DK0764167T3 (da) Bicyclisk lactamhæmmer af interleukin-1-beta-omdannende enzym
NO955074D0 (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
DE69904804T2 (de) Glucocorticoid selektive entzündungshemmende mittel
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
HK1029936A1 (en) Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
BR9809848A (pt) Composição
DE69625230T2 (de) Thrombininhibitoren
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
ATE258063T1 (de) Selektive mmp inhibitoren mit verringerten nebenwirkungen
UY26893A1 (es) Combinación farmacéutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversión de la angiotensina i
ATE227571T1 (de) Thrombin inhibitoren
BG101431A (en) the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR